国际治疗性肿瘤疫苗的开发与研究进展

被引：7

作者：

杜海洲

机构：

[1] 中华医学图书情报杂志社

来源：

药学进展 | 2018年 / 42卷 / 09期

关键词：

治疗性肿瘤疫苗; 抗原疫苗; 肿瘤细胞疫苗; 树突状细胞疫苗; 核酸疫苗; 临床试验;

D O I：

暂无

中图分类号：

R730.51 [免疫疗法];

学科分类号：

100214 ;

摘要：

肿瘤是全球人类第二大死因。一些肿瘤通常难以用像手术、放疗和化疗等常规治疗方法治疗,但可用肿瘤疫苗帮助刺激人体的免疫应答使其得到控制。将疫苗用于由诸如乙型肝炎病毒和人乳头瘤病毒(HPV)等致瘤病毒引起的感染现已非常成功地降低了这些感染导致的肿瘤发病率。治疗性肿瘤疫苗从免疫疗法兴起之初就给人们带来了很大的希望。尽管治疗性肿瘤疫苗在临床试验取得一些成功并有一种治疗前列腺肿瘤的疫苗获得批准,但大多数治疗性疫苗仍在临床试验之中。为了了解国际治疗性肿瘤疫苗的开发与研究现状,依据美国药物研究与生产商协会(Ph RMA)最近发布的报告及临床试验数据库(Clinicaltrials.gov)与相关新药数据库中的数据,重点对进入Ⅲ期临床试验的3种抗原疫苗、3种肿瘤细胞疫苗、6种树突状细胞疫苗、5种核酸疫苗和2种其他治疗性肿瘤疫苗进行了分析和综述。分析结果表明,这19种肿瘤疫苗中许多在中期分析报告中,无论是在延长无复发生存率(RFS)和总生存率(OS)方面,还是在耐受性、安全性等方面,都显示出良好的开发前景。

引用

页码：685 / 696

页数：12

共 18 条

[1] Phase II study of Vigil DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer [J].

Oh, Jonathan ;

Barve, Minal ;

Matthews, Carolyn M. ;

Koon, E. Colin ;

Heffernan, Thomas P. ;

Fine, Bruce ;

Grosen, Elizabeth ;

Bergman, Melanie K. ;

Fleming, Evelyn L. ;

DeMars, Leslie R. ;

West, Loyd ;

Spitz, Daniel L. ;

Goodman, Howard ;

Hancock, Kenneth C. ;

Wallraven, Gladice ;

Kumar, Padmasini ;

Bognar, Ernest ;

Manning, Luisa ;

Pappen, Beena O. ;

Adams, Ned ;

Senzer, Neil ;

Nemunaitis, John .

GYNECOLOGIC ONCOLOGY, 2016, 143 (03) :504-510

[2] A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients [J].

Rodriguez, Pedro C. ;

Popa, Xitllaly ;

Martinez, Odeth ;

Mendoza, Silvia ;

Santiesteban, Eduardo ;

Crespo, Tatiana ;

Amador, Rosa M. ;

Fleytas, Ricardo ;

Acosta, Soraida C. ;

Otero, Yanine ;

Romero, Gala N. ;

de la Torre, Ana ;

Cala, Mireysi ;

Arzuaga, Lina ;

Vello, Loisel ;

Reyes, Delmairis ;

Futiel, Niurka ;

Sabates, Teresa ;

Catala, Mauricio ;

Flores, Yoanna I. ;

Garcia, Beatriz ;

Viada, Carmen ;

Lorenzo-Luaces, Patricia ;

Marrero, Maria A. ;

Alonso, Liuba ;

Parra, Jenelin ;

Aguilera, Nadia ;

Pomares, Yaisel ;

Sierras, Patricia ;

Rodriguez, Gryssell ;

Mazorra, Zaima ;

Lage, Agustin ;

Crombet, Tania ;

Neninger, Elia .

CLINICAL CANCER RESEARCH, 2016, 22 (15) :3782-3790

[3]

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer[J] . Tomasz M Beer,Nicholas Vogelzang,Ji?ina Bart?ňková,Kurt Miller,William Oh,Stephane Oudard,Hardev Pandha,A Oliver Sartor,Radek ?pí?ek,Timothy O Toole,Niels G Borgstein,Winald R Gerritsen.Journal for ImmunoTherapy of Cancer . 2015 (S2)

[4]

RNA-Based Vaccines in Cancer Immunotherapy[J] . Megan A. McNamara,Smita K. Nair,Eda K. Holl,Nathalie Cools.Journal of Immunology Research . 2015

[5] Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer [J].

Podrazil, Michal ;

Horvath, Rudolf ;

Becht, Etienne ;

Rozkova, Daniela ;

Bilkova, Pavla ;

Sochorova, Klara ;

Hromadkova, Hana ;

Kayserova, Jana ;

Vavrova, Katerina ;

Lastovicka, Jan ;

Vrabcova, Petra ;

Kubackova, Katerina ;

Gasova, Zdenka ;

Jarolim, Ladislav ;

Babjuk, Marek ;

Spisek, Radek ;

Bartunkova, Jirina ;

Fucikova, Jitka .

ONCOTARGET, 2015, 6 (20) :18192-18205

[6]

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial[J] . Cornelia L Trimble,Matthew P Morrow,Kimberly A Kraynyak,Xuefei Shen,Michael Dallas,Jian Yan,Lance Edwards,R Lamar Parker,Lynette Denny,Mary Giffear,Ami Shah Brown,Kathleen Marcozzi-Pierce,Divya Shah,Anna M Slager,Albert J Sylvester,Amir Khan,K

[7]

DCVax?-L—Developed by Northwest Biotherapeutics[J] . Stavros Polyzoidis,Keyoumars Ashkan.Human Vaccines & Immunotherapeutics . 2014 (11)

[8] A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan [J].

Rocha-Lima, Caio Max ;

Marques Junior, Eriberto de Queiroz ;

Bayraktar, Soley ;

Broome, Paul ;

Weissman, Charles ;

Nowacki, Marek ;

Leslie, Martin ;

Susnerwala, Shabbir .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) :479-486

[9]

Long Term Follow Up: Phase I Trial of “bi-shRNA furin/GMCSF DNA/Autologous Tumor Cell” Immunotherapy (FANG?) in Advanced Cancer[J] . Neil Senzer,Minal Barve,Jacklyn Nemunaitis,Joseph Kuhn,Anton Melnyk,Peter Beitsch,Mitchell Magee,Jonathan Oh,Cynthia Bedell,Padmasini Kumar,Donald Rao,Beena Pappen,Gladice Wallraven,Charles F,Phillip Maples,John Nemunaitis.Vaccines & Vaccination . 2013 (8)

[10]

Therapeutic Cancer Vaccines[J] . Chunqing Guo,Masoud H. Manjili,John R. Subjeck,Devanand Sarkar,Paul B. Fisher,Xiang-Yang Wang.Advances in Cancer Research . 2013

← 1 2 →